Logo.jpg
Blue Biofuels Receives Canadian Patent on CTS Process
21 mai 2024 17h37 HE | Blue Biofuels, Inc.
PALM BEACH GARDENS, FL, May 21, 2024 (GLOBE NEWSWIRE) -- Blue Biofuels, Inc. (OTCQB: BIOF). Blue Biofuels, Inc., (“the Company”) is pleased to announce that it has received a Notice of Allowance in...
Logo.png
GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
14 mars 2024 08h45 HE | GRI Bio, Inc.
Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases Ongoing efforts to build a robust global patent estate for a...
SeaStar_SM_LogoCard.png
SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology
01 févr. 2024 08h30 HE | SeaStar Medical Holding Corporation
DENVER, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
60Degrees_logo_RGB_Logo.jpg
60 Degrees Pharmaceuticals Awarded Canadian Patent Covering Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects
31 juil. 2023 07h59 HE | Sixty Degrees Pharmaceuticals
Patent provides exclusive use of tafenoquine for prevention of malaria in malaria-naive individuals in Canada until late 2035.Tafenoquine is the active molecule in 60 Degrees Pharmaceuticals’...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
31 mai 2017 07h30 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation
16 déc. 2014 08h38 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the continued expansion of Elite's intellectual property...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
10 mars 2014 07h46 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 10, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the expansion of intellectual property protection surrounding...
P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug
26 avr. 2011 10h15 HE | P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 26, 2011) - www.p2dinc.com ...